Mechanisms of neurotrophic factor protection against calcium- and free radical-mediated excitotoxic injury: Implications for treating neurodegenerative disorders

Experimental Neurology

Volumn 124, Issue 1, 1993, Pages 89-95

  Mattson, Mark P ^a   Cheng, Bin ^a   Smith Swintosky, Virginia L ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BRAIN DERIVED GROWTH FACTOR; CILIARY NEUROTROPHIC FACTOR; EXCITATORY AMINO ACID; FIBROBLAST GROWTH FACTOR; FREE RADICAL; K 252B; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; SOMATOMEDIN B; SOMATOMEDIN C; STAUROSPORINE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL TISSUE; CALCIUM TRANSPORT; NERVE DEGENERATION; NERVE INJURY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMAL; CALCIUM; FREE RADICALS; GROWTH SUBSTANCES; HUMAN; MODELS, NEUROLOGICAL; NERVE GROWTH FACTORS; NERVOUS SYSTEM DISEASES; NEUROTOXINS; RATS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027745628     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1006/exnr.1993.1178     Document Type: Article

References (62)

1. ARAKAWA, Y., M. SENDTNER, and H. THOENEN. 1990. Survival effect of ciliary neurotrophic factor (CNTF) on chick embryonic motoneurons in culture: Comparison with other neurotrophic factors and cytokines. J. Neurosci. 10: 3507-3515.
2. Beal, M. F., N. W. Kowall, D. W. Ellison, M. G. Mazurek, K. J. Swartz, and J. B. Martin. 1986. Replication of the neurochemical characteristics of Huntington’s disease by quinolinic acid. Nature 321: 168-171.
3. CARNEY, J. M., P. E. STARKE-REED, C. N. OLIVER, R. W. LAN-DUM, M. S. CHENG, J. F. Wu, and R. A. FLOYD. 1991. Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-alpha-phenylnitrone. Proc. Natl. Acad. Sci. USA 88: 3633-3636.
4. Cheng, B., and M. P. Mattson. 1991. NGF and bFGF protect rat hippocampal and human cortical neurons against hypoglycemic damage by stabilizing calcium homeostasis. Neuron 7: 1031-1041.
5. Cheng, B., and M. P. Mattson. 1992. IGF-I and IGF-II protect cultured hippocampal and septal neurons against calcium-me-diated hypoglycemic damage. J. Neurosci. 12: 1558-1566.
6. Cheng, B., and M. P. Mattson. 1992. Glucose deprivation elicits neurofibrillary tangle-like antigenic changes in hippocampal neurons: Prevention by NGF and bFGF. Exp. Neurol. 117: 114-123.
7. COLLAZO, D., H. TAKAHASHI, and R. D. G. MCKAY. 1992. Cellular targets and trophic functions of neurotrophin-3 in the developing rat hippocampus. Neuron 9: 643-656.
8. Coyle, J. T., and R. SCHWARCZ. 1976. Lesion of striatal neurons with kainic acid provides a model for Huntington’s Chorea. Nature 263: 244-246.
9. DIFIGLIA, M. 1990. Excitotoxic injury of the neostriatum: A model for Huntington’s disease. Trends Neurosci. 13: 286-289.
10. DYKENS, J. A., A. STERN, and E. TRENKNER. 1987. Mechanism of kainate toxicity to cerebellar neurons in vitro is analagous to reperfusion tissue injury. J. Neurochem. 49: 1222-1228.
11. Elliott, E. M., M. P. Mattson, P. Vanderklish, G. Lynch, I. Chang, and R. M. SAPOLSKY. 1993. Corticosterone exacerbates kainate-induced alterations in hippocampal tau immunoreactiv-ity and spectrin proteolysis in vivo. J. Neurochem. 61: 57-67.
12. Freese, A., S. P. FINKLESTEIN, and M. DiFiglla. 1992. Basic fibroblast growth factor protects striatal neurons in vitro from NMDA-receptor mediated excitotoxicity. Brain Res. 575: 351-355.
13. FRIDEN, P. M., L. R. WALU, P. WATSON, S. R. DOCTROW, J. W. KOZARICH, C. BACKMAN, H. BERGMAN, B. HOFFER, F. BLOOM, and A.-C. GRANHOLM. 1993. Blood-brain barrier penetration and in vivo activity of an NGF conjugate. Science 259: 373-377.
14. Fridovich, I. 1978. Biology of oxygen radicals. Science 201: 875-880.
15. Gluckman, P., N. Klempt, J. Guan, C. Mallard, E. Siri-manne, M. Dragunow, M. Klempt, K. Singh, C. Williams, and K. Nikolics. 1992. A role for IGF-I in the rescue of CNS neurons following hypoxic-ischemic injury. Biochem. Biophys. Res. Commun. 182: 593-599.
16. GREENAMYRE, J. T., and A. B. YOUNG. 1989. Excitatory amino acids and Alzheimer’s disease. Neurobiol. Aging 10: 593-602.
17. HARA, H., H. ONODERA, M. YOSHIDOMI, Y. MATSUDA, and K. KOGURE. 1990. Staurosporine, a novel protein kinase C inhibitor, prevents postischemic neuronal damage in the gerbil and rat. J. Cereb. Blood Flow Matab. 10: 646-653.
18. Hefti, F., J. Hartikka, and B. Knusel. 1989. Function of neurotrophic factors in the adult and aging brain and their possi-ble use in the treatment of neurodegenerative diseases. Neurobiol Aging 10: 515-533.
19. Jackson, G. R., L. Apfell, K. Werrbach-Perez, and J. R. Perez-Polo. 1990. Role of nerve growth factor in oxidant-an-tioxidant balance and neuronal injury. I. Stimulation of hydrogen peroxide resistance. J. Neurosci. Res. 25: 360-368.
20. Jesberger, J. A., and J. S. Richardson. 1991. Oxygen free radicals and brain dysfunction, int. J. Neurosci. 57: 1-17.
21. Kanje, M., A. Skottner, J. Sjoberg, and G. Lundborg. 1989. Insulin-like growth factor-I (IGF-I) stimulates regeneration of rat sciatic nerve. Brain Res. 486: 396-398.
22. Klockgether, T. M., L. M. Turski, Z. M. Zhang, D. M. Gash, R. M. Kurlan, and J. T. Greenamyre. 1991. The AMPA receptor antagonist NBQX has antiparkinsonian effects in mono-amine-depleted rats and MPTP-treated monkeys. Ann. Neurol. 30: 717-723.
23. Koh, J. Y., L. L. Yang, and C. W. Cotman. 1990. 0-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res. 533: 315-320.
24. KUNCL, R. W., L. Jin, and J. D. Rothstein. 1992. Chronic glu-tamate toxicity in motor neurons from organotypic spinal cord cultures. Soc. Neurosci. Abstr. 18: 756.
25. LEWIS, M. E., K. V. CALLISON, and N. Neff. 1992. Is K-252a a non-competitive partial agonist of high affinity NGF receptors? Soc. Neurosci. Abstr. 18: 13.
26. MACDERMOTT, A. B., and N. DALE. 1987. Receptors, ion channels and synaptic potentials underlying the integrative actions of excitatory amino acids. Trends Neurosci. 10: 280-284.
27. MATSUMOTO, S., A. HIRANO, and S. GOTO. 1990. Spinal cord neurofibrillary tangles of Guamanian amyotrophic lateral sclerosis and parkinsonism-dementia complex. Neurology 40: 975-979.
28. MATTSON, M. P., P. B. GUTHRIE, B. C. HAYES, and S. B. KATER. 1989. Roles for mitotic history in the generation and degeneration of hippocampal neuroarchitecture. J. Neurosci. 9: 1223-1230.
29. MATTSON, M. P., M. MURRAIN, P. B. GUTHRIE, and S. B. KATER. 1989. Fibroblast growth factor and glutamate: Opposing actions in the generation and degeneration of hippocampal pyramidal neurons. J. Neurosci. 9: 3728-3740.
30. MATTSON, M. P. 1990. Antigenic changes similar to those seen in neurofibrillary tangles are elicited by glutamate and calcium influx in cultured hippocampal neurons. Neuron 4: 105-117.
31. MATTSON, M. P., B. RYCHUK, C. Chu, and S. CHRISTAKOS. 1991. Evidence of calcium-reducing and excitoprotective roles for the calcium-binding protein calbindin-D28K in cultured hip-pocampal neurons. Neuron 6: 41-51.
32. Mattson, M. P., M. G. Engle, and B. Rychlik. 1991. Effects of elevated intracellular calcium levels on the cytoskeleton and tau in cultured human cerebral cortical neurons. Mol. Chem. Neuropathol. 15: 117-142.
33. MATTSON, M. P. 1992. Calcium as sculptor and destroyer of neural circuitry. Exp. Gerontol. 27: 29-49.
34. Mattson, M. P., B. Cheng, D. Davis, K. Bryant, I. Lieber-burg, and R. E. Rydel. 1992. ß-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12: 376-389.
35. MATTSON, M. P., and B. CHENG. 1993. Growth factors protect neurons against excitotoxic /ischemic insults by stabilizing calcium homeostasis. Stroke, in press.
36. Mattson, M. P., Y. Zhang, and S. Bose. 1993. Growth factors prevent mitochondrial dysfunction, loss of calcium homeostasis and cell injury, but not ATP depletion in hippocampal neurons. Exp. Neurol. 121: 1-13.
37. CHENG, B., S. W. BARGER, and M. P MATTSON. 1994. Staurosporine, K-252a and K-252b stabilize calcium homeostasis and promote survival of CNS neurons in the absence of glucose. J. Neurochem., in press.
38. CHENG, B., S. W. BARGER, and M. P. MATTSON. 1994. Staurosporine, K-252a and K-252b stablilize calcium homeostasis and promote survival of CNS neurons in the absence of glucose. J. Neurochem., in press.
39. Mattson, M. P., K. TOMASELLI, and R. E. Rydel. 1993. Calcium-destabilizing and neurodegenerative effects of aggregated 0-amyloid peptide are attenuated by basic FGF. Brain Res. 21, 35-49.
40. Mattson, M. P., K. Kumar, B. Cheng, H. Wang, and E. K. Michaelis. 1993. Basic FGF regulates the expression of a functional 71 kDa NMDA receptor protein that mediates calcium influx and neurotoxicity in cultured hippocampal neurons. J. Neurosci. 13: 4575-4588.
41. Mitani, A., Y. Oomura, H. Yanase, and K. Kataoka. 1992. Acidic fibroblast growth factor delays in vitro ischemia-induced intracellular calcium elevation in gerbil hippocampal slices: A sign of neuroprotection. Neurochem. Int. 21: 337-341.
42. Miyamoto, M., T. H. Murphy, R. L. Schnaar, and J. T. Coyle. 1989. Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line. J. Pharmacol. Exp. Ther. 250: 1132-1140.
43. Nakata, N., H. Kato, and K. Kogure. 1993. Protective effects of basic fibroblast growth factor against hippocampal neuronal damage following cerebral ischemia in the gerbil. Brain Res. 605: 354-356.
44. Nistico, G., M. R. Cirio lo, D. Fiskin, M. Iannone, A. DeMar-tino, and G. Rotilio. 1992. NGF restores decrease in catalase activity and increases superoxide dismutase and glutathione peroxidase activity in the brain of aged rats. Free Rad. Biol. Med. 12: 177-181.
45. Nozaki, K., S. P. Finklestein, and M. F. Beal. 1993. Basic fibroblast growth factor protects against hypoxia/ischemia and NMDA neurotoxicity in neonatal rats. J. Cereb. Blood Flow Me-tab. 13: 221-228.
46. Olney, J. W., C. F. Zorumski, M. T. Price, G. G. Wang, and J. LABRUYERE. 1990. Excitotoxicity of 1-DOPA and 6-OH-DOPA: Implications for Parkinson’s and Huntington’s diseases. Exp. Neurol. 108: 269-272.
47. Olson, L., A. Nordberg, H. Vonholst, L. Backman, T. Eben-dal, I. Alafuzoff, K. Amberla, P. Harwivig, A. Herlitz, A. Lilja, et al. 1992. Nerve growth factor affects C-11-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient—case report. J. Neurol. Trans. (Parkinsons) 4: 79-84.
48. Pechan, P. A., K. Chodhury, and W. Seifert. 1992. Free radicals induce gene expression of NGF and bFGF in rat astrocyte culture. NeuroReport 3: 469-472.
49. Prehn, J. H. M., C. Backhaub, and J. Krieglstein. 1993. Transforming growth factor ß prevents glutamate neurotoxicity in rat neocortical cultures and protects mouse from ischemic injury in vivo. J. Cereb. Blood Flow Metab. 13: 521-525.
50. Rosen, D. R., T. Siddique, D. Patterson, D. A. Figlewicz, P. Sapp, et al. 1993. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59-62.
51. ROTHSTEIN, J. D., L. J. MARTIN, and R. W. KUNCL. 1992. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N. Engl. J. Med. 326: 1464-1468.
52. SASAKI, K., Y. OOMURA, K. SUZUKI, K. HANAI, and H. YAGI. 1992. Acidic fibroblast growth factor prevents death of hippo-campal CAI pyramidal cells following ischemia. Neurochem. Int. 21: 397-402.
53. SCHLESSINGER, J., and A. ULRICH. 1992. Growth factor signaling by receptor tyrosine kinases. Neuron 9: 383-391.
54. SELKOE, D. J. 1989. Biochemistry of altered brain proteins in Alzheimer’s disease. Annu. Rev. Neurosci. 12: 463-490.
55. SENDTNER, M., G. W. KREUTZBERG, and H. THOENEN. 1990. Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy. Nature 345: 440-441.
56. SHANKAR, S. K., R. YANAGIHARA, R. M. GARRUTO, I. G. IQBAL, K. S. KOSIK, and D. C. GADJUSEK. 1989. Immunocytochemical characterization of neurofibrillary tangles in amyotrophic lateral sclerosis and parkinsonism-dementia of Guam. Ann. Neurol. 25: 146-151.
57. SHIGENO, T., T. MIMA, K. TAKAKURA, D. I. GRAHAM, G. KATO, Y. HASHIMOTO, and S. FURUKAWA. 1991. Amelioration of delayed neuronal death in hippocampus by nerve growth factor. J. Neurosci. 11: 2914-2919.
58. SIESJO, B. K., F. BENGTSSON, W. GRAMPP, and S. THEANDER. 1989. Calcium, excitotoxins, and neuronal death in the brain. Ann. N.Y. Acad. Sci. 568: 234-251.
59. SPINA, M. B., S. P. SQUINTO, J. MILLER, R. M. LINDSAY, and C. HYMAN. 1992. Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and JV-methyl-4-phenylpyridinium ion toxicity: Involvement of glutathione system. J. Neurochem. 59: 99-106.
60. VOLL, C. L., and R. N. AUER. 1991. Insulin attenuates ischemic brain damage independent of its hypoglycemic effect. J. Cereb. Blood Flow Metab. 11: 1006-1014.
61. WATSON, B. D., and M. D. GINSBERG. 1989. Ischemic injury in the brain: Role of oxygen radical-mediated processes. Ann. N. Y. Acad. Sci. 559: 269-281.
62. ZHANG, Y., T. TATSUNO, J. M. CARNEY, and M. P. MATTSON. 1993. Basic FGF, NGF, and IGFs protect hippocampal and corti-cal neurons against iron-induced degeneration. J. Cereb. Blood Flow Metab. 13: 378-388.